India TodayCenter·
Rare eye-risk claims put GLP-1 drugs under sharper scrutiny
Rare eyerisk claims put GLP drugs under sharper scrutiny
Read at India Today →
US · 1 sources covering this
Rare eye-risk claims put GLP-1 drugs under sharper scrutiny
Rare eyerisk claims put GLP drugs under sharper scrutiny
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/5b8f47a0ea25991f33492fc7e7a4014b94d0474f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Rare eye-risk claims put GLP-1 drugs under sharper scrutiny"></iframe>
